Precursor Cell Lymphoblastic Leukemia-Lymphoma: all 2,121 studies
Page 13 of 22. Open to participants first (492), then studies with results posted, then the rest; newest registration first within each.
- CD19 Chimeric Antigen Receptor (CAR) T Cells for Adults With Recurrent or Refractory B Cell MalignanciesActive, not recruitingNCT04214886Phase 1
- Study of CD19 Specific Chimeric Antigen Receptor Positive T Cells (CAR-T) in ALL and NHLStatus unknownNCT04206943Phase 1/2
- A Clinical Study of CAR-T Cells Treatment for Children With CD19+/CD22+ R/R ALL and LymphomaStatus unknownNCT04204161Phase 1
- Evaluation of Therapeutic Video Games for Pre-school Children With Acute Lymphoblastic LeukemiaCompletedNCT04199637Not applicable
- Treatment of Hematological Malignancy With Novel CAR-T Cells.Status unknownNCT04191941Early Phase 1
- The Association Between Asparaginase Enzyme Activity Levels and Toxicities in Childhood Acute Lymphoblastic Leukaemia in NOPHOALL 2008CompletedNCT04187248
- The Clinical Application of Chimeric Antigen Receptor T Cells in the Treatment of CD19 Positive Recurrent Refractory B Cell-derived Hematological MalignanciesStatus unknownNCT04184414Early Phase 1
- Study of alloCART-19 Cell Therapy in Pediatric Patients With Relapsed/Refractory B-Cell Acute Lymphoblastic LeukemiaActive, not recruitingNCT04173988Early Phase 1
- Pharmacogenetic Study of Antimitotic Therapies Involved in Hepatic VOD in Children With Nephroblastoma or ALLCompletedNCT04168788Not applicable
- Muscle Dysfunction in Patients With Hematological Diseases Referred to Stem Cell TransplantActive, not recruitingNCT04167683
- The Clinical Study of CD19 UCAR-T Cells in Patients With B-cell Acute Lymphoblastic Leukemia (B-ALL)Status unknownNCT04166838Early Phase 1
- A Retrospective Study of Patients With Leukemia Relapse in the CNS Treated With CAR T CellsStatus unknownNCT04158011
- Study of Tisagenlecleucel in Chinese Pediatric and Young Adult Subjects With Relapsed or Refractory B-cell ALLWithdrawnNCT04156659Phase 2
- CTA101 UCAR-T Cell Injection for Treatment of Relapsed or Refractory CD19+ B-cell Acute Lymphoblastic LeukemiaStatus unknownNCT04154709Phase 1
- Dose-Escalation Study of Oral Administration of LP-108 as Monotherapy and in Combination With Azacitidine in Patients With Relapsed or Refractory MDS, CMML, or AMLCompletedNCT04139434Phase 1
- A Study of GC022F CAR-T Cell Immunotherapy for Relapsed or Refractory B- ALLStatus unknownNCT04129099Early Phase 1
- Karate or Kung Fu?Status unknownNCT04120896Not applicable
- Transcranial Direct Current Stimulation of the Temporal Cortex in Survivors of Childhood Acute Lymphoblastic Leukemia (ALL)Active, not recruitingNCT04105530Not applicable
- Effect of Vitamin D Diffiency on Oral Mucosa in Patients Recieving Methotrexate ChemotherapyStatus unknownNCT04096846
- Safety and Efficacy of Dual Specificity CD19 and CD22 CAR-T Cell Immunotherapy in R/R Acute B Lymphoblastic LeukemiaWithdrawnNCT04094766Phase 1
- FoxO3a and PU.1 in Acute Lymphoblastic LeukemiaStatus unknownNCT04092348
- CD22-CAR T Cells in Children and Young Adults With B Cell MalignanciesCompletedNCT04088864Phase 1
- Yttrium-90 Anti CD66 Monoclonal Antibody in Childhood Relapsed/Refractory LeukaemiaCompletedNCT04082286Phase 1
- First in Human Study of Ziftomenib in Relapsed or Refractory Acute Myeloid LeukemiaActive, not recruitingNCT04067336Phase 1/2
- Lymphoproliferative Disorders After Diagnosis of Childhood Acute Lymphoblastic Leukemia/LymphomaStatus unknownNCT04055558
- The SMART CART Study: Health Information TechnologyCompletedNCT04051216Not applicable
- CAR-20/19-T Cells in Patients With Relapsed/Refractory B Cell ALLTerminatedNCT04049383Phase 1
- Blinatumomab for MRD in Pre-B ALL Patients Following Stem Cell TransplantTerminatedNCT04044560Phase 2
- CD19-CD22 Chimeric Antigen Receptor T (CAR-T) Cell for Treatment of B Cell Acute Lymphoblastic Leukemia (B-ALL)TerminatedNCT04034446Early Phase 1
- Modified Immune Cells (CD19-CD22 CAR T Cells) in Treating Patients With Recurrent or Refractory CD19 Positive, CD22 Positive Leukemia or LymphomaWithdrawnNCT04029038Phase 1/2
- The Registry of Oncology Outcomes Associated with Testing and TreatmentCompletedNCT04028479
- Effects of Exercises on Total Body Health in Children With Acute Lymphoblastic LeukemiaCompletedNCT04015882Not applicable
- Collect and Assess Tissue Samples From Subjects With Hematologic MalignancyCompletedNCT04014764
- Precision-T: A Study of Orca-T in Recipients Undergoing Allogeneic Transplantation for Hematologic MalignanciesActive, not recruitingNCT04013685Phase 1
- Study Evaluating the Efficacy and Safety With CD19CAR-T for Relapsed or Refractory Acute Lymphoblastic LeukemiaStatus unknownNCT04012879Phase 1
- Humanized CD19 Chimeric Antigen Receptor (CAR)-Modified T Cell Therapy in Treating Patients With B-cell MalignanciesStatus unknownNCT04008251Phase 1
- Anti-CD22 Chimeric Antigen Receptor (CAR)-Modified T Cell Therapy for Relapsed Refractory B-cell MalignanciesStatus unknownNCT04007978Phase 1
- CD7 CAR-T Cells for Patients With R/R CD7+ NK/T Cell Lymphoma,T-lymphoblastic Lymphoma and Acute Lymphocytic LeukemiaStatus unknownNCT04004637Phase 1
- Personalized Targeted Preparative Regimen Before T-depleted Allogeneic HSCT in Children With Chemoresistent Acute LeukemiasStatus unknownNCT04000698Phase 3
- Inotuzumab Ozogamicin and Chemotherapy in Treating Patients With Recurrent or Refractory B-cell Acute Lymphoblastic LeukemiaCompletedNCT03991884Phase 1
- Health Care Utilisation Among Survivors of Childhood Acute Lymphoblastic LeukaemiaCompletedNCT03985826
- The Value of Follow-Up After Childhood Acute Lymphoblastic Leukaemia in Denmark - Family PerspectivesWithdrawnNCT03985215
- CD19 CAR-T Consolidation Therapy for Acute Lymphoblastic LeukemiaActive, not recruitingNCT03984968Phase 1/2
- Allogeneic Donor Lymphocyte Infusions Combined With BlinatumomabWithdrawnNCT03982992Phase 2
- Comparison of Gastrointestinal Motility in Healthy Children and Children With ConstipationStatus unknownNCT03981510Not applicable
- Irradiation-based Myeloablative Conditioning Followed by Treg/Tcon Immunotherapy in HSCTStatus unknownNCT03977103Phase 2
- Dietary Intake, Sarcopenic Obesity, and Other Treatment-Related Outcomes in Indian Children With Acute Lymphoblastic LeukemiaActive, not recruitingNCT03974893
- Reduced IV Fluids to Improve Clearance of HDMTX in Children w/Lymphoma or Acute Lymphoblastic LeukemiaCompletedNCT03964259Phase 1
- Phase I Study of Inotuzumab With Augmented BFM Re-Induction for Patients With Relapsed/Refractory B-cell ALLActive, not recruitingNCT03962465Phase 1
- Phase I/II Study of Rapcabtagene Autoleucel in CLL, 3L+ DLBCL, r/r ALL and 1L HR LBCLActive, not recruitingNCT03960840Phase 1/2
- Study of Escalating Doses of INA03 Administered Intravenously as Single Agent in Adult Patients With Relapse/Refractory Acute LeukemiaCompletedNCT03957915Early Phase 1
- Determinants of Mercaptopurine Toxicity in Paediatric Acute Lymphoblastic Leukemia Maintenance TherapyStatus unknownNCT03920813Phase 4
- Anti-CD19/CD22 Bispecific Chimeric Antigen Receptor（CAR)-T Cell Therapy for Measurable Residual Disease(MRD) Positive ALLCompletedNCT03919526Phase 1
- CAR-T Cell Therapy Targeting to CD19 for R/R ALLActive, not recruitingNCT03919240Phase 1/2
- Inotuzumab Ozogamicin for Children With MRD Positive CD22+ Lymphoblastic LeukemiaTerminatedNCT03913559Phase 2
- Clinical Transplant-Related Long-term Outcomes of Alternative Donor Allogeneic Transplantation (BMT CTN 1702)CompletedNCT03904134Not applicable
- CD19 hsCAR-T for Refractory/Relapsed CD19+ B-ALL PatientsStatus unknownNCT03902197Phase 2
- ItaliaN Observational Study of Patients With Acute Lymphoblastic Leukemia Treated With Anti-CD22 ImmunoconjugateCompletedNCT03898128
- Detection of IKZF1 Deletion Mutation in Patients With Acute Lymphoblastic Leukemia and Its Impact in TherapyStatus unknownNCT03889951
- Intravenous Ixazomib in Pediatric Participants With Relapsed or Refractory Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LLy)WithdrawnNCT03888534Phase 1
- Evaluation of a Donor Testing Kit for the Prediction of AGVHD in Patient Receiving a Peripheral Blood Stem Cell AllograftStatus unknownNCT03887156Phase 2/3
- VPA Expanded UCB Transplantation for Treatment of Patients With Hematological MalignanciesCompletedNCT03885947Phase 1
- Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME TrialTerminatedNCT03878524Phase 1
- Ex Vivo Drug Sensitivity Testing and Mutation ProfilingCompletedNCT03860376
- CD19 CAR-T Cell Therapy for Relapsed/Refractory B-cell Lymphoma and B-cell Acute Lymphoblastic LeukemiaStatus unknownNCT03854994Phase 1
- Inotuzumab Ozogamicin and Vincristine Sulfate Liposome in Treating Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic LeukemiaWithdrawnNCT03851081Phase 1/2
- An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical TrialActive, not recruitingNCT03844048Phase 3
- Senl_1904A and Senl_1904B Chimeric Antigen Receptor （CAR） T-Cell in the Treatment of r/ r Acute B Lymphocytic LeukemiaStatus unknownNCT03840317Phase 1
- A Study of Zilovertamab Vedotin (MK-2140) (VLS-101) in Participants With Hematologic Malignancies (MK-2140-001)CompletedNCT03833180Phase 1
- A Study of GC022 CAR-T Cell Immunotherapy for Relapsed or Refractory B- ALLStatus unknownNCT03825731Early Phase 1
- A Study of GC007F CAR-T Cell Immunotherapy for Relapsed or Refractory B- ALLCompletedNCT03825718Early Phase 1
- SCT in Ph Positive Acute Lymphoblastic LeukemiaCompletedNCT03821727
- A Comparison of Reduced Dose Total Body Irradiation (TBI) and Cyclophosphamide With Fludarabine and Melphalan Reduced Intensity Conditioning in Adults With Acute Lymphoblastic Leukaemia (ALL) in Complete Remission. (ALL-RIC)Active, not recruitingNCT03821610Phase 2
- Rivogenlecleucel Donor Lymphocyte Immunotherapy in Treating Patients With Recurrent Blood Cancers After Stem Cell TransplantWithdrawnNCT03807063Phase 1
- Clinical Significance of Occult Central Nervous System Disease In Adult Acute Lymphoblastic LeukemiaCompletedNCT03803670
- Human CD19 Targeted T Cells Injection Therapy for Relapsed and Refractory CD19-positive LeukemiaStatus unknownNCT03798509Phase 1
- Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell TransplantActive, not recruitingNCT03779854Phase 2
- CD19.CAR-multiVSTs for Patients With CD19+ B-ALL or NHL Undergoing Related Allogeneic HSCT (CARMA)WithdrawnNCT03768310Phase 1
- Cardiovascular Function in Acute LeukemiaCompletedNCT03760237
- Blinatumomab Plus HLA-Mismatched Cellular Therapy for Relapsed/Refractory CD19+ ALLCompletedNCT03751709Phase 1
- Efficacy and Toxicity of Blinatumomab in the French ATU for Adult BCP-ALL R/R, or With MRD+ (FRENCH-CYTO)CompletedNCT03751072
- REALIB-LLA-2017: Idelalisib in Patients With Acute Lymphoblastic LeukemiaTerminatedNCT03742323Phase 1/2
- Ribociclib in Combination With Everolimus and Dexamethasone in Relapsed ALLActive, not recruitingNCT03740334Phase 1
- Flotetuzumab in Treating Patients With Recurrent or Refractory CD123 Positive Blood CancerWithdrawnNCT03739606Phase 2
- A Randomized Phase II Study of Hyperbaric Oxygen in Improving Engraftment in Umbilical Cord Blood Stem Cell TransplantActive, not recruitingNCT03739502Phase 2
- Blinatumomab in High-risk B-cell Precursor Acute Lymphoblastic LeukemiaActive, not recruitingNCT03709719Phase 2
- Iclusig PMS in CML or Ph+ALL PatientsStatus unknownNCT03709017
- International Trial of Selumetinib in Combination With Dexamethasone for the Treatment of Acute Lymphoblastic LeukaemiaTerminatedNCT03705507Phase 1/2
- IMRT-TMI With Fludarabine as Myeloablative Conditioning for Allogeneic HSCTTerminatedNCT03696537Phase 1
- CART19 Cells Treatment of MRD of B Cell Malignancies and Then Auto-HSCTStatus unknownNCT03685786Phase 1
- CD19 CAR-T Cells for Patients With Relapse and Refractory CD19+ B-ALL.Status unknownNCT03671460Phase 1
- Asparaginase Activity Monitoring (AAM) in Adult Patients With Acute Lymphoblastic Leukemia (ALL)TerminatedNCT03668392Phase 2
- The Impact of Exercise Approaches on Sleep in Children With Acute Lymphoblastic LeukemiaCompletedNCT03664947Not applicable
- Impact of an Orthotic Intervention in Children With Peripheral NeuropathyCompletedNCT03655587Not applicable
- HLA 10/10 Matched Unrelated Donor vs Haploidentical Allogenic Hematopoietic Stem Cell TransplantationStatus unknownNCT03655145Phase 3
- CALLS: CML and Ph+ALL Low Level Mutation Prevalence SurveyCompletedNCT03647215
- Autologous CAR-T/TCR-T Cell Immunotherapy for MalignanciesStatus unknownNCT03638206Phase 1/2
- Tisagenlecleucel vs Blinatumomab or Inotuzumab for Patients With Relapsed/Refractory B-cell Precursor Acute Lymphoblastic LeukemiaWithdrawnNCT03628053Phase 3
- Optimal Methods of Disease Detection in Children and Young Adults With Acute Lymphoblastic Leukemia in the Pediatric Oncology BranchCompletedNCT03627208
- Effect of Prophylactic TKI Therapy Post-transplants on Ph+ ALL Undergoing Allo-HSCT With MRD Positive Pre-transplantsStatus unknownNCT03624530Phase 2/3